Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CASTLE BIOSCIENCES INC Director's Dealing 2021

May 14, 2021

32601_dirs_2021-05-14_b7597c4c-5981-44b4-bce9-a1f26633951f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CASTLE BIOSCIENCES INC (CSTL)
CIK: 0001447362
Period of Report: 2021-05-13

Reporting Person: MAETZOLD DEREK J (Director, Pres. & Chief Exec. Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-05-13 Common Stock S 886 $49.748 Disposed 558466 Direct
2021-05-13 Common Stock S 1547 $50.508 Disposed 556919 Direct
2021-05-13 Common Stock S 600 $51.638 Disposed 556319 Direct
2021-05-13 Common Stock S 300 $52.747 Disposed 556019 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 156460 Indirect
Common Stock 179300 Indirect
Common Stock 166700 Indirect

Footnotes

F1: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 11, 2020.

F2: This transaction was executed in multiple trades at prices ranging from $49.260 to $50.250, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $50.285 to $51.215, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $51.320 to $52.150, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: This transaction was executed in multiple trades at prices ranging from $52.500 to $52.940, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6: Held by DJM Grantor Retained Annuity Trust No. 1 of which the Reporting Person is the trustee and beneficiary.

F7: Held by The Maetzold Descendants 2020 Trust of which the Reporting Person's spouse is the trustee and the Reporting Person's spouse and their children are beneficiaries.

F8: Held by Derek Maetzold 2020 Irrevocable Trust of which the Reporting Person is the trustee and his children are beneficiaries.